Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 58 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-10 Hoang Peter L. President and CEO Grant or award · Employee Stock Option (Right to Buy) +41,200 41,200
2020-03-10 Hoang Peter L. President and CEO Grant or award · Employee Stock Option (Right to Buy) +388,800 388,800
2020-03-10 Vera Juan Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +26,600 26,600
2020-03-10 Vera Juan Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +113,400 113,400
2020-03-10 Szymanska Anna Vice President, Quality Grant or award · Employee Stock Option (Right to Buy) +7,500 7,500
2020-03-10 Szymanska Anna Vice President, Quality Grant or award · Employee Stock Option (Right to Buy) +32,500 32,500
2020-03-10 Loiacono Michael Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +20,900 20,900
2020-03-10 Loiacono Michael Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +119,100 119,100
2020-03-10 Koneru Mythili Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +23,900 23,900
2020-03-10 Koneru Mythili Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +116,100 116,100
2020-03-10 Kim Anthony H. Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +32,500 32,500
2020-03-10 Kim Anthony H. Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +127,500 127,500
2020-03-10 Hoang Tsvetelina P VP, Research and Development Grant or award · Employee Stock Option (Right to Buy) +14,600 14,600
2020-03-10 Hoang Tsvetelina P VP, Research and Development Grant or award · Employee Stock Option (Right to Buy) +25,400 25,400
2020-03-10 Garrett Gerald Vice President, Clinical Ops. Grant or award · Employee Stock Option (Right to Buy) +1,700 1,700
2020-03-10 Garrett Gerald Vice President, Clinical Ops. Grant or award · Employee Stock Option (Right to Buy) +38,300 38,300
2020-03-10 Agopyan Nadia VP, Regulatory Affairs Grant or award · Employee Stock Option (Right to Buy) +7,300 7,300
2020-03-10 Agopyan Nadia VP, Regulatory Affairs Grant or award · Employee Stock Option (Right to Buy) +32,700 32,700
2020-02-18 Eastern Capital LTD 10% owner Option exercise +416,667 $1.20 $500K 4,050,001
2020-02-18 Eastern Capital LTD 10% owner Option exercise · Series A-1 Warrant −416,667 0

Page 5 of 6 · 119 trades